BC Platforms
1997
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series B
LATEST DEAL TYPE
$9.7M
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer and provider of a genome data management platform designed to optimize decision-making in drug development and delivery. The company's data management platform leverages data integration, secure analysis and interpretation of molecular and clinical information, enabling health organizations to address health challenges.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Business/Productivity Software
Other Industries
Other Healthcare Technology Systems
Database Software
Primary Office
- Bleicherweg 10
- 8002 Zürich
- Switzerland
+41 044 000 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BC Platforms’s full profile, request a free trial.
BC Platforms Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 09-May-2017 | $9.7M | 00.00 | 000.00 | Completed | Generating Revenue |
| 1. Grant | 18-Aug-2014 | Completed | Generating Revenue |
BC Platforms Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Series A | 00,000 |
BC Platforms Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MedeAnalytics | Private Equity-Backed | Richardson, TX | 000 | 0000 | 000000000000 | 0000 |
| 00000 00000000 | Venture Capital-Backed | Cambridge, United Kingdom | 00.000 | 000000000000 | 00.000 | |
| 0000000 | Venture Capital-Backed | Rijswijk, Netherlands | 00 | 000.00 | 00000000000 | 000.00 |
| 00000000 | Venture Capital-Backed | New York, NY | 00 | 000 | 0000000000 | 000 |
| 0000000000 | Venture Capital-Backed | San Francisco, CA | 000 | 000.00 | 000000 0 |
BC Platforms Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| BioMedPartners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Boston Millennia Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| Debiopharm Innovation Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Finnish Industry Investment | Fund of Funds | Minority | 000 0000 | 000000 0 | ||
| Tekes | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |
BC Platforms Executive Team (8)
2 Former Executives
You’re viewing 5 of 8 executives. Get the full list »BC Platforms Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Erich Platzer Ph.D | Self | Board Member | 000 0000 | |
| Hannu Vaajoensuu | Self | Board Member | 000 0000 | |
| Jari Heikkinen | Self | Board Member | 000 0000 | |
| Mark Bidwell | Self | Chairman of the Board | 000 0000 | |
| Nino da Silva | BC Platforms | Co-Founder, Executive Vice President of Sales & Marketing & Board Member | 000 0000 |